Literature DB >> 9630155

Treatment of detrusor sphincter dyssynergia by transperineal injection of botulinum toxin.

P Gallien1, S Robineau, M Verin, M P Le Bot, B Nicolas, R Brissot.   

Abstract

Detrusor-sphincter dyssynergia is an involuntary contraction of the external urethral sphincter during the detrusor contraction. It causes voiding dysfunction and can lead to urologic complications such as hydroureteronephrosis and renal failure. Patients with spinal cord injuries are particularly vulnerable. Botulinum toxin has been used via cystoscopy to decrease the activity of the external urethral sphincter. This report describes the treatment of 5 tetraplegic patients by single transperineal injections of botulinum toxin for detrusor-sphincter dyssynergia, proved by a urodynamic study with electromyography. A total of 15 injections was given, resulting in improved bladder function in all patients. Urodynamic assessment after treatment showed an increase of the functional detrusor capacity and a decrease of the maximal detrusor pressure during voiding. These results confirm the consideration of botulinum toxin as a treatment for detrusor sphincter dyssynergia. A single transperineal injection is a valuable, less invasive treatment using a cystoscopic technique.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9630155     DOI: 10.1016/s0003-9993(98)90050-8

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  14 in total

Review 1.  Bladder outlet obstruction in women: prevalence, recognition, and management.

Authors:  R Patel; V Nitti
Journal:  Curr Urol Rep       Date:  2001-10       Impact factor: 3.092

Review 2.  [Botulinum toxin in urology. Indications and results].

Authors:  B Schurch; A Reitz
Journal:  Urologe A       Date:  2004-11       Impact factor: 0.639

Review 3.  Botox in urology.

Authors:  Ali Thwaini; Iqbal Shergill; Suresh Radhakrishnan; Frank Chinegwundoh; Hadeel Thwaini
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-11-19

4.  Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients.

Authors:  P Gallien; J-M Reymann; G Amarenco; B Nicolas; M de Sèze; E Bellissant
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

5.  Botulinum toxin therapy: its use for neurological disorders of the autonomic nervous system.

Authors:  Dirk Dressler
Journal:  J Neurol       Date:  2012-08-10       Impact factor: 4.849

Review 6.  Management of bladder, prostatic and pelvic floor disorders.

Authors:  G Brisinda; G Maria; A R Bentivoglio; F Cadeddu; G Marniga; F Brandara; A Albanese
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

7.  Predictors of outcome for urethral injection of botulinum toxin to treat detrusor sphincter dyssynergia in men with spinal cord injury.

Authors:  J M Soler; J G Previnaire; N Hadiji
Journal:  Spinal Cord       Date:  2015-12-29       Impact factor: 2.772

Review 8.  [Botulinum toxin in urology. An inventory].

Authors:  H Schulte-Baukloh; H H Knispel
Journal:  Urologe A       Date:  2004-08       Impact factor: 0.639

Review 9.  Hitting below the belt (bladder): botulinum treatment of urethral and prostate disorders.

Authors:  H Henry Lai; Christopher P Smith
Journal:  Curr Urol Rep       Date:  2007-09       Impact factor: 3.092

Review 10.  Use of Botulinum Toxin A in the Treatment of Lower Urinary Tract Disorders: A Review of the Literature.

Authors:  David C Moore; Joshua A Cohn; Roger R Dmochowski
Journal:  Toxins (Basel)       Date:  2016-03-23       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.